tiprankstipranks
Advertisement
Advertisement
Roivant Sciences rises 11.7%
PremiumThe FlyRoivant Sciences rises 11.7%
4d ago
Roivant Sciences reports Q4 EPS 28c, consensus (35c)
Premium
The Fly
Roivant Sciences reports Q4 EPS 28c, consensus (35c)
4d ago
Notable open interest changes for May 19th
Premium
The Fly
Notable open interest changes for May 19th
5d ago
Roivant Sciences price target raised to $34 from $30 at Jefferies
PremiumThe FlyRoivant Sciences price target raised to $34 from $30 at Jefferies
2M ago
Roivant Advances Brepocitinib Program, Refocuses Autoimmune Portfolio
Premium
Company Announcements
Roivant Advances Brepocitinib Program, Refocuses Autoimmune Portfolio
2M ago
Roivant reports new clinical program for brepocitinib in lichen planopilaris
Premium
The Fly
Roivant reports new clinical program for brepocitinib in lichen planopilaris
2M ago
Video: Moderna advances as settlement seen removing share overhang
PremiumThe FlyVideo: Moderna advances as settlement seen removing share overhang
3M ago
Morning Movers: Moderna rises after entering COVID settlement agreement
Premium
The Fly
Morning Movers: Moderna rises after entering COVID settlement agreement
3M ago
Unlocking Value from IP Settlement and Pipeline Catalysts: Why Roivant Deserves a Buy Rating
Premium
Ratings
Unlocking Value from IP Settlement and Pipeline Catalysts: Why Roivant Deserves a Buy Rating
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100